625 related articles for article (PubMed ID: 18473497)
1. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
[TBL] [Abstract][Full Text] [Related]
2. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
3. Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme.
Nwokedi EC; DiBiase SJ; Jabbour S; Herman J; Amin P; Chin LS
Neurosurgery; 2002 Jan; 50(1):41-6; discussion 46-7. PubMed ID: 11844233
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
5. Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience.
Ciammella P; Galeandro M; D'Abbiero N; Podgornii A; Pisanello A; Botti A; Cagni E; Iori M; Iotti C
Clin Neurol Neurosurg; 2013 Sep; 115(9):1609-14. PubMed ID: 23453151
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme.
Einstein DB; Wessels B; Bangert B; Fu P; Nelson AD; Cohen M; Sagar S; Lewin J; Sloan A; Zheng Y; Williams J; Colussi V; Vinkler R; Maciunas R
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):668-74. PubMed ID: 22445005
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas.
Gannett D; Stea B; Lulu B; Adair T; Verdi C; Hamilton A
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):461-8. PubMed ID: 7673034
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).
Combs SE; Widmer V; Thilmann C; Hof H; Debus J; Schulz-Ertner D
Cancer; 2005 Nov; 104(10):2168-73. PubMed ID: 16220556
[TBL] [Abstract][Full Text] [Related]
9. Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis.
Panet-Raymond V; Souhami L; Roberge D; Kavan P; Shakibnia L; Muanza T; Lambert C; Leblanc R; Del Maestro R; Guiot MC; Shenouda G
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):473-8. PubMed ID: 18554821
[TBL] [Abstract][Full Text] [Related]
10. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
11. High-dose-rate stereotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes.
Chang CN; Chen WC; Wei KC; Ng SH; Ho YS; Huang DY; Lee SP; Hong JH
J Neurooncol; 2003 Jan; 61(1):45-55. PubMed ID: 12587795
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgery versus fractionated stereotactic radiotherapy boost for patients with glioblastoma multiforme.
Cho KH; Hall WA; Lo SS; Dusenbery KE
Technol Cancer Res Treat; 2004 Feb; 3(1):41-9. PubMed ID: 14750892
[TBL] [Abstract][Full Text] [Related]
13. Survival following stereotactic radiosurgery for newly diagnosed and recurrent glioblastoma multiforme: a multicenter experience.
Villavicencio AT; Burneikiene S; Romanelli P; Fariselli L; McNeely L; Lipani JD; Chang SD; Nelson EL; McIntyre M; Broggi G; Adler JR
Neurosurg Rev; 2009 Oct; 32(4):417-24. PubMed ID: 19633875
[TBL] [Abstract][Full Text] [Related]
14. CyberKnife Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy As First-line Treatments for Imaging-diagnosed Intracranial Meningiomas.
Manabe Y; Murai T; Ogino H; Tamura T; Iwabuchi M; Mori Y; Iwata H; Suzuki H; Shibamoto Y
Neurol Med Chir (Tokyo); 2017 Dec; 57(12):627-633. PubMed ID: 29021413
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.
Piroth MD; Gagel B; Pinkawa M; Stanzel S; Asadpour B; Eble MJ
Strahlenther Onkol; 2007 Dec; 183(12):695-702. PubMed ID: 18040615
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and toxicity of CyberKnife re-irradiation and "dose dense" temozolomide for recurrent gliomas.
Conti A; Pontoriero A; Arpa D; Siragusa C; Tomasello C; Romanelli P; Cardali S; Granata F; De Renzis C; Tomasello F
Acta Neurochir (Wien); 2012 Feb; 154(2):203-9. PubMed ID: 21984132
[TBL] [Abstract][Full Text] [Related]
18. Factors predictive of improved overall survival following stereotactic radiosurgery for recurrent glioblastoma.
Bir SC; Connor DE; Ambekar S; Wilden JA; Nanda A
Neurosurg Rev; 2015 Oct; 38(4):705-13. PubMed ID: 25864406
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in glioblastoma multiforme patients receiving high-dose particle radiotherapy or conventional radiotherapy.
Matsuda M; Yamamoto T; Ishikawa E; Nakai K; Zaboronok A; Takano S; Matsumura A
Br J Radiol; 2011 Dec; 84 Spec No 1(Spec Iss 1):S54-60. PubMed ID: 21427185
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
